Transforming Cardiology Clinical Trial Recruitment
At Trialbee, we connect people living with cardiovascular conditions to innovative clinical trials designed to prevent disease progression, improve heart health, and enhance quality of life. Through patient-centric strategies and data-driven insights, we help sponsors accelerate recruitment, improve representation, and bring new cardiology therapies to patients faster.
Key Challenges in Cardiology Trials
Cardiology studies face significant recruitment barriers due to complex eligibility criteria, comorbidities, and low patient awareness of clinical research opportunities. These challenges can delay timelines, limit diversity, and drive up study costs.
-
Complex Eligibility Criteria
Cardiovascular trials often require precise inclusion criteria based on biomarkers, imaging, or prior treatment history — making it difficult to identify qualified participants quickly.
-
Comorbidity Burden
Many cardiac patients live with multiple chronic conditions such as diabetes, hypertension, or kidney disease, complicating recruitment and protocol adherence.
-
Limited Awareness & Trust
Despite the prevalence of heart disease, many patients are unaware that clinical trials could be part of their care options or remain hesitant due to misconceptions about safety and accessibility.
The result: slow enrollment, high screen-failure rates, and missed opportunities to reach patients who could benefit from cutting-edge cardiovascular therapies.
Trialbee’s Solution
At Trialbee, we deliver patient-focused, technology-driven recruitment strategies tailored for cardiovascular clinical trials. Our digital ecosystem combines omnichannel outreach, medical pre-qualification, and transparent analytics — all designed to accelerate enrollment while maintaining quality.
Precision Recruitment & Omnichannel Reach
We meet patients where they are — across digital health platforms, social media, community health networks, and advocacy organizations. Trialbee leverages behavioral insights, real-world data, and targeted engagement to connect with verified, motivated participants.
Two-Stage Medical Pre-Qualification
Each referred patient completes digital pre-screening and eligibility verification based on key cardiology criteria such as cholesterol levels, blood pressure, and treatment history. This ensures that sites receive pre-qualified, informed participants ready to take part.
Real-Time Visibility & Analytics with Honey™ Platform
Our Honey™ platform provides transparent, real-time insights into recruitment performance, referral status, and site-level progress. Sponsors and CROs can monitor every step of the patient journey — enabling proactive, data-driven decision-making.
Proven Experience Across Key Indications
- Atrial Fibrillation (Afib)
- Cardiovascular disease and chronic kidney disease (CVD/CKD)
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
- Heart Failure
- Heart Failure With Preserved Ejection Fraction HFpEF
- Pulmonary Arterial Hypertension (PAH)
Purpose-Built Creative for Cardiology Trials
Cardiovascular disease impacts every aspect of a patient’s life — from energy and mobility to confidence and independence. Trialbee develops empathetic, inclusive campaigns that highlight real patient stories and emphasize the hope that research brings. Our creative approach reflects the strength and diversity of the cardiac community, ensuring every message connects authentically and inspires participation.
Case Study: Trialbee Over-Delivers in Patient Recruitment for Global Program
A top 10 pharmaceutical company partnered with Trialbee to launch a multi-country cardiovascular program in 8 weeks, rapidly recruiting ~100,000 patients. With hundreds of sites involved, unqualified referrals could overwhelm staff, risking delays, budget overruns, and the program’s success.
Let’s Partner for Better, Faster Recruitment
Trialbee helps you connect with qualified cardiac patients — faster. Discover how our technology, data, and human-centered approach deliver measurable recruitment success.
